Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | SBS | NDSN |
|---|---|---|
| Price | $5.24 | $327.46 |
| Change today | ▼ 1.28% | ▼ 0.12% |
| Market cap | $18.43B | $18.24B |
| Return, 3 months | -8.8% | +11.1% |
| Return, year to date | +10.7% | +37.4% |
| Return, 1 year | +12.7% | +45.1% |
| P/E (TTM) | 11.4 | 33.1 |
| P/B | 2.1 | 5.6 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | 2.79% | 1.00% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | +11.2% |
| Analyst buy share | – | 75% |
| RSI (14) | 57 | 62 |
| 30-day volatility | 28.8% | 28.8% |
| Max drawdown, 1 year | -37.0% | -14.1% |
| Trend read | Leaning bullish | Strong uptrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
